Associations between human blood metabolome and vascular dementia

IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY Progress in Neuro-Psychopharmacology & Biological Psychiatry Pub Date : 2024-09-19 DOI:10.1016/j.pnpbp.2024.111150
Yiming Jia , Daoxia Guo , Yi Liu , Lulu Sun , Xinyue Chang , Yu He , Mengyao Shi , Guo-Chong Chen , Yonghong Zhang , Li Hui , Zhengbao Zhu
{"title":"Associations between human blood metabolome and vascular dementia","authors":"Yiming Jia ,&nbsp;Daoxia Guo ,&nbsp;Yi Liu ,&nbsp;Lulu Sun ,&nbsp;Xinyue Chang ,&nbsp;Yu He ,&nbsp;Mengyao Shi ,&nbsp;Guo-Chong Chen ,&nbsp;Yonghong Zhang ,&nbsp;Li Hui ,&nbsp;Zhengbao Zhu","doi":"10.1016/j.pnpbp.2024.111150","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Effective and specific biomarkers are warranted for the management of vascular dementia. We aimed to systematically screen the human blood metabolome to identify potential mediators of vascular dementia via a two-sample Mendelian randomization (MR) design.</div></div><div><h3>Methods</h3><div>We selected 93 unique blood metabolites from 3 metabolome genome-wide association studies (GWASs) with a total of 147,827 participants of European ancestry. Summary statistics for vascular dementia originated from a European-descent GWAS dataset released by the FinnGen Study, involving 859 cases and 211,300 controls. We applied the inverse-variance weighted MR method in the main analysis to examine the causal roles of blood metabolites in vascular dementia, followed by several sensitivity analyses for robustness validation.</div></div><div><h3>Results</h3><div>Genetically determined glycoproteins (OR per 1-SD increase, 0.75; 95 % CI, 0.68–0.83, <em>P</em> = 1.08 × 10<sup>−8</sup>) and <em>O</em>-methylascorbate (OR per 1-SD increase, 0.08; 95 % CI, 0.02–0.32; <em>P</em> = 3.74 × 10<sup>−4</sup>) levels had negative associations with the risk of vascular dementia, whereas genetically determined total cholesterol (OR per 1-SD increase, 1.77; 95 % CI, 1.32–2.38; <em>P</em> = 1.39 × 10<sup>−4</sup>) and low-density lipoprotein (LDL) cholesterol (OR per 1-SD increase, 1.94; 95 % CI, 1.48–2.55; <em>P</em> = 1.61 × 10<sup>−6</sup>) levels had positive associations with the risk of vascular dementia. MR-Egger regression suggested no directional pleiotropy for the identified associations, and sensitivity analyses with different MR models further confirmed these findings.</div></div><div><h3>Conclusion</h3><div>Glycoproteins, <em>O</em>-methylascorbate, total cholesterol, and LDL cholesterol might be promising blood markers of vascular dementia, which may provide novel insights into the prevention of vascular dementia. Further studies are warranted to replicate our findings and elucidate the potential mechanistic pathways.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":null,"pages":null},"PeriodicalIF":5.3000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0278584624002185","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Effective and specific biomarkers are warranted for the management of vascular dementia. We aimed to systematically screen the human blood metabolome to identify potential mediators of vascular dementia via a two-sample Mendelian randomization (MR) design.

Methods

We selected 93 unique blood metabolites from 3 metabolome genome-wide association studies (GWASs) with a total of 147,827 participants of European ancestry. Summary statistics for vascular dementia originated from a European-descent GWAS dataset released by the FinnGen Study, involving 859 cases and 211,300 controls. We applied the inverse-variance weighted MR method in the main analysis to examine the causal roles of blood metabolites in vascular dementia, followed by several sensitivity analyses for robustness validation.

Results

Genetically determined glycoproteins (OR per 1-SD increase, 0.75; 95 % CI, 0.68–0.83, P = 1.08 × 10−8) and O-methylascorbate (OR per 1-SD increase, 0.08; 95 % CI, 0.02–0.32; P = 3.74 × 10−4) levels had negative associations with the risk of vascular dementia, whereas genetically determined total cholesterol (OR per 1-SD increase, 1.77; 95 % CI, 1.32–2.38; P = 1.39 × 10−4) and low-density lipoprotein (LDL) cholesterol (OR per 1-SD increase, 1.94; 95 % CI, 1.48–2.55; P = 1.61 × 10−6) levels had positive associations with the risk of vascular dementia. MR-Egger regression suggested no directional pleiotropy for the identified associations, and sensitivity analyses with different MR models further confirmed these findings.

Conclusion

Glycoproteins, O-methylascorbate, total cholesterol, and LDL cholesterol might be promising blood markers of vascular dementia, which may provide novel insights into the prevention of vascular dementia. Further studies are warranted to replicate our findings and elucidate the potential mechanistic pathways.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人类血液代谢组与血管性痴呆之间的关系
背景:血管性痴呆症的治疗需要有效而特异的生物标志物。我们旨在通过双样本孟德尔随机化(MR)设计系统地筛选人类血液代谢组,以确定血管性痴呆的潜在介导因素:我们从3项代谢组全基因组关联研究(GWAS)中选取了93种独特的血液代谢物,共有147827名欧洲血统的参与者参与了研究。血管性痴呆的汇总统计数据来自芬兰基因研究(FinnGen Study)发布的欧洲血统 GWAS 数据集,其中包括 859 例病例和 211,300 例对照。我们在主要分析中采用了逆方差加权MR方法来研究血液代谢物在血管性痴呆中的因果作用,随后又进行了几项敏感性分析以验证其稳健性:基因决定的糖蛋白(每增加 1-SD OR,0.75;95 % CI,0.68-0.83,P = 1.08 × 10-8)和 O-甲基抗坏血酸(每增加 1-SD OR,0.08;95 % CI,0.02-0.32;P = 3.74 × 10-4)水平与血管性痴呆风险呈负相关,而基因决定的总胆固醇(每增加 1-SD OR,1.77;95 % CI,1.32-2.38;P = 1.39 × 10-4)和低密度脂蛋白(LDL)胆固醇(OR 每增加 1-SD,1.94;95 % CI,1.48-2.55;P = 1.61 × 10-6)水平与血管性痴呆风险呈正相关。MR-Egger回归表明,已确定的关联不存在方向性多重效应,使用不同MR模型进行的敏感性分析进一步证实了这些发现:结论:糖蛋白、O-甲基抗坏血酸、总胆固醇和低密度脂蛋白胆固醇可能是血管性痴呆有希望的血液标志物,可为预防血管性痴呆提供新的见解。我们有必要开展进一步研究,以复制我们的发现并阐明潜在的机理途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
12.00
自引率
1.80%
发文量
153
审稿时长
56 days
期刊介绍: Progress in Neuro-Psychopharmacology & Biological Psychiatry is an international and multidisciplinary journal which aims to ensure the rapid publication of authoritative reviews and research papers dealing with experimental and clinical aspects of neuro-psychopharmacology and biological psychiatry. Issues of the journal are regularly devoted wholly in or in part to a topical subject. Progress in Neuro-Psychopharmacology & Biological Psychiatry does not publish work on the actions of biological extracts unless the pharmacological active molecular substrate and/or specific receptor binding properties of the extract compounds are elucidated.
期刊最新文献
Functional connectivity changes in males with nicotine addiction: A triple network model study. Structural and functional alterations in different types of delusions across schizophrenia spectrum: A systematic review Shared polygenic susceptibility to treatment response in severe affective and psychotic disorders: Evidence from GWAS data sets Duration of aversive memory in zebrafish after a single shock Abnormal intrinsic brain functional network dynamics in stroke and correlation with neuropsychiatric symptoms revealed based on lesion and cerebral blood flow
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1